PODCAST

Pulmonary Medicine

ReachMD

science & medicine medicine

All Episodes

00:00:00

Pulmonary Hypertension for Advanced Practice...

Pulmonary Medicine ·

2024/10/17

Host: Martha Kingman, DNP, FNP-C Guest: Susanne McDevitt, DNP, ACNP-BC This program focuses on early symptom identification and timely diagnosis in patients with pulmonary hypertension (PH). Learn how appropriate risk stratification can facilitate the effective management of PH. Our experts also stress the importance of asking the right questions and offer strategies for achieving well-rounded communication with patients and their caregivers.

00:00:00

Updates From the 7th World Symposium Task Force

Pulmonary Medicine ·

2024/10/11

Guest: Eric D. Austin, MD, MSCI Guest: Hilary M. DuBrock, MD Guest: H. James Ford, MD Guest: Gustavo A. Heresi, MD, MS Guest: Gergely Meszaros, JD, MSc Guest: Oksana A. Shlobin, MD Guest: Ioana Preston, MD Guest: Lucilla Piccari, MD, PhD The 7th World Symposium Task Force on Pulmonary Hypertension focused on the standard of care, best practices, and emerging clinical data in the treatment of pulmonary hypertension (PH). For the first time, the 2024 Symposium

00:00:00

Severe Asthma: An Exploratory Study on Mucus Plugging

Pulmonary Medicine ·

2024/04/12

Host: Charles Turck, PharmD, BCPS, BCCCP Guest: Arnaud Bourdin, MD, PhD Since many severe asthma patients have been shown to have mucus plugs, it’s important to understand the role they plan in severe asthma. Join us as we discuss an exploratory study and the role of mucus plugging in severe asthma with Dr. Charles Turck and Professor Arnaud Bourdin. Professor Bourdin is the Head of Pulmonology at the Arnaud de Villeneuve Hospital in Montpellier, France. TEZSPIRE is a registered

00:00:00

Novel Immune Checkpoint Strategies in Non-Small Cell...

Pulmonary Medicine ·

2024/02/09

Host: Jacob Sands, MD Guest: Aakesh Desai, MD, MPH According to research featured at the 2023 ASCO Annual Meeting, novel immune checkpoint targets have the potential to inform drug development and combination strategies to optimize the care of patients with non-small cell lung cancer. Tune in to hear Dr. Jacob Sands explore the key findings with Dr. Aakash Desai, an Assistant Professor of Medicine at the O’Neal Cancer Center at the University of Alabama at Birmingham.

00:00:00

NSCLC Care: Evaluating Durvalumab in the First-Line...

Pulmonary Medicine ·

2023/12/28

Host: Jacob Sands, MD Guest: Liza Villaruz, MD According to a recent study, the immune checkpoint inhibitor durvalumab is not only considered safe, but it may also offer overall survival benefits for individuals with advanced or metastatic non-small cell lung cancer (NSCLC) and restricted performance status. Here to talk about this research are Dr. Jacob Sands and Dr. Liza Villaruz, Associate Professor of Medicine at the University of Pittsburgh School of Medicine.

00:00:00

Epoprostenol: A Look at a Last-Line Inhalation...

Pulmonary Medicine ·

2023/12/20

Host: Charles Turck, PharmD, BCPS, BCCCP Guest: Justin Reinert, PharmD Acute respiratory distress syndrome (ARDS) is a severe lung condition characterized by the rapid onset of widespread inflammation in the lungs, but inhaled epoprostenol can be used as a last-line treatment strategy for these patients. Learn more about this treatment option’s efficacy and safety with Dr. Charles Turck and Dr. Justin Reinert, Assistant Professor of Clinical Pharmacy at the University of

00:00:00

COPD Care Redefined: A Review of the Updated GOLD...

Pulmonary Medicine ·

2023/11/17

Host: Andrew Wilner, MD, FACP, FAAN Guest: Neil Skolnik, MD The Global Initiative for Chronic Obstructive Lung Disease (GOLD) recently updated some of the recommendations for treating patients with chronic obstructive pulmonary disease (COPD). Two large conceptual changes occurred in this update: one is an increased emphasis on treating exacerbations, and the other is looking at decreasing mortality as an important treatment goal. Learn more about this and other key updates from

00:00:00

Breathing Beyond Birth: The Symptoms and Treatment of...

Pulmonary Medicine ·

2023/11/15

Host: Jennifer Shu, MD, FAAP Guest: Steven H. Abman, MD Bronchopulmonary dysplasia is a chronic lung disease that can have significant impacts on a newborn’s overall respiratory health, making it imperative to know how to recognize and treat it. Tune in to hear Dr. Jennifer Shu talk about the symptoms, impacts, and treatment of bronchopulmonary dysplasia with Dr. Steven Abman, a Professor in the Department of Pediatrics at the University of Colorado School of Medicine and the

00:00:00

Managing Immunotherapy Toxicities in Lung Cancer...

Pulmonary Medicine ·

2023/05/22

Host: Jacob Sands, MD Guest: Aliyah Pabani, MD Lung cancer patients undergoing immunotherapy may be at risk for developing life-threatening toxicities. Find out how you can manage them with Dr. Jacob Sands and Dr. Aliyah Pabani, Clinical Assistant Professor in the Department of Medicine at the University of Calgary and Director of the Alberta Immunotherapy Database.

00:00:00

Exploring the Role of Biomarkers in Lung Cancer...

Pulmonary Medicine ·

2023/04/25

Host: Jacob Sands, MD Guest: Biagio Ricciuti, MD Treatment for lung cancer can be complex, but PL-L1 expression and tumor mutational burden might help us select the best treatment for our patients. What do we need to know about the role of these biomarkers in the treatment of lung cancer? To discuss this, Dr. Jacob Sands is joined by Dr. Biagio Ricciuti, a medical oncologist at the Dana-Farber Cancer Institute.

00:00:00

The STELLAR Trial: Key Data on Sotatercept for PAH

Pulmonary Medicine ·

2023/03/17

Host: Marius M. Hoeper, MD A recent study explored the safety and efficacy of sotatercept on top of background pulmonary arterial hypertension (PAH) therapy. To learn more about this clinical data, Dr. Marius M. Hoeper, a Professor of Medicine and the Deputy Director of the Department of Respiratory Medicine at Hannover Medical School in Hannover, Germany, dives into the results of this trial and explores how they may impact patients with PAH.

00:00:00

Exploring Novel Tools for PAH: Measuring Severity...

Pulmonary Medicine ·

2022/10/18

Host: Matthew Sorrentino, MD Guest: Michael A. Solomon, MD, MBA Guest: Sean Agbor-Enoh, MD, PhD Pulmonary arterial hypertension (PAH) is a rare, and even fatal, condition that can impair the chest and lungs. But could a new blood test help us better assess disease severity and survivability in patients with PAH? To dive deeper into this topic, Dr. Matthew Sorrentino is joined by Dr. Michael Solomon and Dr. Sean Agbor-Enoh from the National Institutes of Health.

00:00:00

Recognizing the Role of Capmatinib for METex14 in NSCLC

Pulmonary Medicine ·

2022/10/13

Host: Jacob Sands, MD Guest: Edward B. Garon, MD, MS Recently approved capmatinib may be a new treatment for patients with metastatic non-small cell lung cancer who have MET exon 14 skipping mutations. To learn more about this emerging treatment option, Dr. Jacob Sands speaks with Dr. Edward Garon from the David Geffen School of Medicine at the University of California in Los Angeles to explore data from the GEOMETRY Mono-1 study.

00:00:00

Checkpoint Inhibitor Combination Therapy for...

Pulmonary Medicine ·

2021/09/13

Host: Jacob Sands, MD Guest: Shirish Gadgeel, MD Immunotherapy using checkpoint inhibitors has become a standard of practice in advanced non-small cell lung cancer. But can combination therapy further improve patient outcomes? Dr. Jacob Sands is joined by Dr. Shirish Gadgeel, Chief of the Division of Hematology and Oncology at Henry Ford Cancer Institute, who recently spoke about this topic at the American Society of Clinical Oncology’s annual meeting.

00:00:00

Serving the Underserved: The Role of CT Scans in Lung...

Pulmonary Medicine ·

2021/08/03

Host: Jacob Sands, MD Guest: Derek Raghavan, MD, PhD, FACP, FRACP CT scans have the potential to dramatically improve lung cancer outcomes, but are underserved communities receiving access to these types of screenings? Dr. Jacob Sands joins Dr. Derek Raghavan, President of Atrium Health Levine Cancer Institute in Charlotte, North Carolina, to discuss his research presented at the American Society of Clinical Oncology Annual Meeting.

00:00:00

Exploring Advances in Treatment: A Step Forward in...

Pulmonary Medicine ·

2021/06/09

Host: Jacob Sands, MD Guest: Millie Das, MD What are some of the latest advancements in small cell lung cancer? Dr. Jacob Sands discusses small-cell lung cancer treatment developments with Dr. Millie Das, a Clinical Associate Professor of Medical Oncology at Stanford University and Chief of Oncology at the Veteran’s Affairs Palo Alto Healthcare System.

00:00:00

Evaluating Biomarkers at Work in NSCLC

Pulmonary Medicine ·

2021/05/25

Host: Jacob Sands, MD Guest: Mark Awad, MD, PhD What do we need to know about the role of biomarkers in non-small cell lung cancer? Dr. Mark Awad from the Dana-Farber Cancer Institute explains.

00:00:00

Investigating Immunotherapy & Its Role in NSCLC

Pulmonary Medicine ·

2021/05/25

Host: Jacob Sands, MD Guest: Mark Awad, MD, PhD Immunotherapy has led to impressive results, but when is it needed? Dr. Jacob Sands discusses the role of immunotherapy in managing lung cancer with Dr. Mark Awad, a thoracic medical oncologist, Clinical Director of the Lowe Center for Thoracic Oncology at the Dana-Farber Cancer Institute, and Assistant Professor of Medicine at Harvard Medical School.

00:00:00

Reacting to RET Inhibitors: A Look at Progression &...

Pulmonary Medicine ·

2021/05/04

Guest: D. Ross Camidge, MD, PhD After starting on a RET inhibitor, what do you do? Dr. Ross Camidge, the Director of the Thoracic Oncology Clinical and Clinical Research Programs at the University of Colorado, breaks down the progression of RET inhibitors in patients with non-small cell lung cancer and what tests should be utilized throughout the process.

00:00:00

Concerning Kinases: Therapeutic Considerations for...

Pulmonary Medicine ·

2021/05/04

Guest: D. Ross Camidge, MD, PhD With only two targeted therapy options available for RET rearranged advanced non-small cell lung cancer, how do we select the best approach? Dr. Ross Camidge, the Director of the Thoracic Oncology Clinical and Clinical Research Programs at the University of Colorado, discusses treatment options for NSCLC.

242 results

Pulmonary Medicine

All Episodes

Similar Podcasts

Eye On The Sky

Vermont Public

Cienciaes.com

cienciaes.com

This Week in Virology

Vincent Racaniello

Hablando con Científicos - Cienciaes.com

cienciaes.com

The Elective Rotation: A Critical Care Hospital Pharmacy Podcast

Pharmacy Joe